DASATINIB REGULATES LNCRNA EXPRESSIONS IN CHRONIC MYELOID LEUKEMIA

被引：0
|
作者：
Kayabas, C. [1 ]
Sisiler, S. Yilmaz [1 ]
Balci, T. [1 ]
Yelken, B. Ozmen [1 ]
Mutlu, Z. [1 ]
Caliskan, C. [1 ]
Goker, B. [1 ]
Avci, I. Biray [1 ]
Sahin, F. [2 ]
Saydam, G. [2 ]
Gunduz, C. [1 ]
机构：
[1] Ege Univ, Sch Med, Dept Med Biol, Izmir, Turkey
[2] Ege Univ, Sch Med, Dept Hematol, Izmir, Turkey
来源：
LEUKEMIA RESEARCH | 2014年 / 38卷
关键词：
D O I：
10.1016/S0145-2126(14)70172-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PP-118
引用
收藏
页码：S64 / S64
页数：1
相关论文
共 50 条
  • [21] Systematic analysis reveals a lncRNA-miRNA-mRNA network associated with dasatinib resistance in chronic myeloid leukemia
    Luo, Jiawen
    Gao, Yin
    Lin, Xiaomin
    Guan, Xiaoying
    ANNALS OF PALLIATIVE MEDICINE, 2021, 10 (02) : 1727 - 1738
  • [22] Pharmacokinetics of generic dasatinib in the management of chronic myeloid leukemia in the chronic phase
    孔军
    China Medical Abstracts(Internal Medicine), 2017, 34 (01) : 53 - 54
  • [23] A Comprehensive Echocardiographic Assessment of Patients With Chronic Myeloid Leukemia on Dasatinib
    Chen, Chen
    Hernandez, Maria P.
    Altman, Jessica
    Appadurai, Vinesh
    Akhter, Nausheen
    CIRCULATION, 2023, 148
  • [24] Successful pregnancy involving a man with chronic myeloid leukemia on dasatinib
    Oweini, Houssam
    Otrock, Zaher K.
    Mahfouz, Rami A. R.
    Bazarbachi, Ali
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2011, 283 (01) : 133 - 134
  • [25] Comparison of Dasatinib, Nilotinib, and Imatinib in the Treatment of Chronic Myeloid Leukemia
    Ciarcia, Roberto
    Damiano, Sara
    Puzio, Maria Valeria
    Montagnaro, Serena
    Pagnini, Francesco
    Pacilio, Carmen
    Caparrotti, Giuseppe
    Bellan, Cristiana
    Garofano, Tiziana
    Polito, Maria Sole
    Giordano, Antonio
    Florio, Salvatore
    JOURNAL OF CELLULAR PHYSIOLOGY, 2016, 231 (03) : 680 - 687
  • [26] Dasatinib: A Guide to Its Use in Chronic Myeloid Leukemia in the EU
    Keating, Gillian M.
    Lyseng-Williamson, Katherine A.
    McCormack, Paul L.
    Keam, Susan J.
    BIODRUGS, 2013, 27 (03) : 275 - 279
  • [27] Gynecomastia in a male after dasatinib treatment for chronic myeloid leukemia
    G Caocci
    S Atzeni
    N Orrù
    L Azzena
    L Martorana
    R Littera
    A Ledda
    G La Nasa
    Leukemia, 2008, 22 : 2127 - 2128
  • [28] Reactive follicular hyperplasia on dasatinib treatment for chronic myeloid leukemia
    Alessandra Iurlo
    Cristina Bucelli
    Daniele Cattaneo
    Nicola Orofino
    Juri Alessandro Giannotta
    Manuela Zappa
    Umberto Gianelli
    Agostino Cortelezzi
    Annals of Hematology, 2017, 96 : 1953 - 1954
  • [29] Dasatinib: A Guide to Its Use in Chronic Myeloid Leukemia in the EU
    Gillian M. Keating
    Katherine A. Lyseng-Williamson
    Paul L. McCormack
    Susan J. Keam
    BioDrugs, 2013, 27 : 275 - 279
  • [30] Reactive follicular hyperplasia on dasatinib treatment for chronic myeloid leukemia
    Iurlo, Alessandra
    Bucelli, Cristina
    Cattaneo, Daniele
    Orofino, Nicola
    Giannotta, Juri Alessandro
    Zappa, Manuela
    Gianelli, Umberto
    Cortelezzi, Agostino
    ANNALS OF HEMATOLOGY, 2017, 96 (11) : 1953 - 1954
12345